Moderna shares soar over 50% on melanoma drug trial success
Moderna shares, identified by the ticker $MRNA, soared over 50% following reported success in a melanoma drug trial. The post also included the $MRK ticker and links to two social-media posts.
The information on this website is generated using AI and we cannot guarantee its accuracy.
Please use it as reference information only.